New York Life Investment Management LLC Lyell Immunopharma, Inc. Transaction History

New York Life Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$1.71 - $3.07 $62,137 - $111,557	36,338 Added 24.64%	183,805 $409,000
Q4 2023 Feb 05, 2024	SELL	$1.39 - $2.35 $4,724 - $7,987	-3,399 Reduced 2.25%	147,467 $286,000
Q3 2023 Nov 07, 2023	SELL	$1.45 - $3.35 $34,462 - $79,619	-23,767 Reduced 13.61%	150,866 $221,000
Q2 2023 Aug 04, 2023	SELL	$1.89 - $3.86 $51,510 - $105,200	-27,254 Reduced 13.5%	174,633 $555,000
Q1 2023 May 08, 2023	BUY	$1.97 - $3.58 $397,717 - $722,755	201,887 New	201,887 $476,000

122

142M

18.1K

200

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $273M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.